Form 4: Amgen EVP Jonathan P. Graham Reports Stock Disposal for Tax Obligations

Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., reports disposing of 686 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• On April 30, 2024, Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., disposed of 686 shares of Amgen common stock.
• The transaction was executed to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
• The price per share for the disposal was $276.38.
• Following the transaction, Graham directly owns 33,546 shares of Amgen common stock, which includes vested and unvested RSUs and dividend equivalents (DEs).

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by a company insider, and it doesn't inherently convey positive or negative sentiment.

Future Outlook

The document outlines the vesting schedule for Jonathan P. Graham's remaining Restricted Stock Units (RSUs) over the next few years.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like Jonathan P. Graham, trade their company's stock; this provides transparency to the market.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units (RSUs) to align management's interests with those of shareholders.
• The vesting schedules and terms of these equity grants are typically benchmarked against industry peers to ensure competitiveness and retention.
• Companies like Johnson & Johnson, Pfizer, and Merck also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.
• The disposal is related to tax obligations, which is a normal part of executive compensation.

Key Dates